Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest George Institute for Global Health in Sydney Stories

2012-10-17 11:24:54

SYDNEY, Oct. 17, 2012 /PRNewswire/ -- A landmark study by Australian and New Zealand researchers has found that a widely used starch fluid for resuscitation of patients in intensive care units (ICUs) provides no clinical benefit and its use results in increased acute kidney failure (haemodialysis) when compared to normal saline. The findings of CHEST (The Crystalloid vs Hydroxyethyl Starch Trial) have the potential to change the way patients are treated in ICUs across the world....